Cargando…

Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests

OBJECTIVE: The 2019 ASCCP Risk-Based Management Consensus Guidelines present a paradigm shift from results- to risk-based management. Patient and provider factors can affect guideline adoption. We sought feedback from stakeholders to inform guideline development. MATERIALS AND METHODS: To solicit pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkins, Rebecca B., Fuzzell, Lindsay N., Lake, Paige, McIntyre, McKenzie, Nayar, Ritu, Saraiya, Mona, Loukissas, Jennifer, Felder, Tamika, Guido, Richard S., Vadaparampil, Susan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147423/
https://www.ncbi.nlm.nih.gov/pubmed/32243312
http://dx.doi.org/10.1097/LGT.0000000000000524
_version_ 1783520418050605056
author Perkins, Rebecca B.
Fuzzell, Lindsay N.
Lake, Paige
McIntyre, McKenzie
Nayar, Ritu
Saraiya, Mona
Loukissas, Jennifer
Felder, Tamika
Guido, Richard S.
Vadaparampil, Susan T.
author_facet Perkins, Rebecca B.
Fuzzell, Lindsay N.
Lake, Paige
McIntyre, McKenzie
Nayar, Ritu
Saraiya, Mona
Loukissas, Jennifer
Felder, Tamika
Guido, Richard S.
Vadaparampil, Susan T.
author_sort Perkins, Rebecca B.
collection PubMed
description OBJECTIVE: The 2019 ASCCP Risk-Based Management Consensus Guidelines present a paradigm shift from results- to risk-based management. Patient and provider factors can affect guideline adoption. We sought feedback from stakeholders to inform guideline development. MATERIALS AND METHODS: To solicit provider feedback, we surveyed attendees at the 2019 ASCCP annual meeting regarding readiness to adopt proposed changes and used a web-based public comment period to gauge agreement/disagreement with preliminary guidelines. We elicited patient feedback via a brief survey on preferences around proposed recommendations for treatment without biopsy. Surveys and public comment included both closed-ended and free-text items. Quantitative results were analyzed using descriptive statistics; qualitative results were analyzed using content analysis. Results were incorporated into guideline development in real time. RESULTS: Surveys indicated that 98% of providers currently evaluate their patients' past results to determine management; 88% felt formally incorporating history into management would represent an improvement in care. Most providers supported expedited treatment without biopsy: 22% currently perform expedited treatment and 60% were willing to do so. Among patients, 41% preferred expedited treatment, 32% preferred biopsy before treatment, and the remainder were undecided. Responses from the public comment period included agreement/disagreement with preliminary guidelines, reasons for disagreement, and suggestions for improvement. CONCLUSIONS: Stakeholder feedback was incorporated into the development of the 2019 ASCCP Risk-Based Management Consensus Guidelines. Proposed recommendations with less than two-thirds agreement in the public comment period were considered for revision. Findings underscore the importance of stakeholder feedback in developing guidelines that meet the needs of patients and providers.
format Online
Article
Text
id pubmed-7147423
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-71474232020-04-24 Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests Perkins, Rebecca B. Fuzzell, Lindsay N. Lake, Paige McIntyre, McKenzie Nayar, Ritu Saraiya, Mona Loukissas, Jennifer Felder, Tamika Guido, Richard S. Vadaparampil, Susan T. J Low Genit Tract Dis Risk Based Guidelines OBJECTIVE: The 2019 ASCCP Risk-Based Management Consensus Guidelines present a paradigm shift from results- to risk-based management. Patient and provider factors can affect guideline adoption. We sought feedback from stakeholders to inform guideline development. MATERIALS AND METHODS: To solicit provider feedback, we surveyed attendees at the 2019 ASCCP annual meeting regarding readiness to adopt proposed changes and used a web-based public comment period to gauge agreement/disagreement with preliminary guidelines. We elicited patient feedback via a brief survey on preferences around proposed recommendations for treatment without biopsy. Surveys and public comment included both closed-ended and free-text items. Quantitative results were analyzed using descriptive statistics; qualitative results were analyzed using content analysis. Results were incorporated into guideline development in real time. RESULTS: Surveys indicated that 98% of providers currently evaluate their patients' past results to determine management; 88% felt formally incorporating history into management would represent an improvement in care. Most providers supported expedited treatment without biopsy: 22% currently perform expedited treatment and 60% were willing to do so. Among patients, 41% preferred expedited treatment, 32% preferred biopsy before treatment, and the remainder were undecided. Responses from the public comment period included agreement/disagreement with preliminary guidelines, reasons for disagreement, and suggestions for improvement. CONCLUSIONS: Stakeholder feedback was incorporated into the development of the 2019 ASCCP Risk-Based Management Consensus Guidelines. Proposed recommendations with less than two-thirds agreement in the public comment period were considered for revision. Findings underscore the importance of stakeholder feedback in developing guidelines that meet the needs of patients and providers. Lippincott Williams & Wilkins 2020-04-02 /pmc/articles/PMC7147423/ /pubmed/32243312 http://dx.doi.org/10.1097/LGT.0000000000000524 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCCP. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Risk Based Guidelines
Perkins, Rebecca B.
Fuzzell, Lindsay N.
Lake, Paige
McIntyre, McKenzie
Nayar, Ritu
Saraiya, Mona
Loukissas, Jennifer
Felder, Tamika
Guido, Richard S.
Vadaparampil, Susan T.
Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests
title Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests
title_full Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests
title_fullStr Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests
title_full_unstemmed Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests
title_short Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests
title_sort incorporating stakeholder feedback in guidelines development for the management of abnormal cervical cancer screening tests
topic Risk Based Guidelines
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147423/
https://www.ncbi.nlm.nih.gov/pubmed/32243312
http://dx.doi.org/10.1097/LGT.0000000000000524
work_keys_str_mv AT perkinsrebeccab incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT fuzzelllindsayn incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT lakepaige incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT mcintyremckenzie incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT nayarritu incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT saraiyamona incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT loukissasjennifer incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT feldertamika incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT guidorichards incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests
AT vadaparampilsusant incorporatingstakeholderfeedbackinguidelinesdevelopmentforthemanagementofabnormalcervicalcancerscreeningtests